Health and Healthcare

AbbVie : ABBV

All AbbVie Articles

602 Articles

Chris Lange | Oct 25, 2019 at 9:59 AM EDT

Short Sellers Can’t Make Up Their Minds on Big Pharma

The October 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Jon C. Ogg | Oct 15, 2019 at 6:35 AM EDT

20 Dividend Stocks for All Baby Boomers to Retire On

Here are 20 companies that should offer investors who are retired or near retirement some added income to help make…

Chris Lange | Oct 14, 2019 at 10:05 AM EDT

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Allergan has finally announced that its shareholders have voted to approve the company’s acquisition of AbbVie. The acquisition is expected…

Chris Lange | Oct 10, 2019 at 9:40 AM EDT

Big Pharma Sees Rising Tide in Short Interest

The September 30 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Sep 28, 2019 at 9:10 AM EDT

6 Large-Cap and Mega-Cap Stocks Where Analysts See Large Upside Potential

The week of September 28 saw many analyst upgrades and positive calls in blue-chip stocks. Here are six that received…

Lee Jackson | Sep 27, 2019 at 10:45 AM EDT

Why Dividend-Paying Large-Cap Pharmaceuticals Could Shine in Q4

These four top large-cap pharmaceutical stocks for investors to consider all pay solid dividends and look like very solid fourth-quarter…

Lee Jackson | Sep 26, 2019 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Boston Beer, Carvana, HD Supply, Marathon Petroleum, Square, Trade Desk, Whirlpool and More

Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Boston Beer, Carvana, HD Supply, Marathon Petroleum, Square, Trade Desk and…

Chris Lange | Sep 25, 2019 at 9:20 AM EDT

Short Sellers Grow More Selective in Big Pharma

The September 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Jon C. Ogg | Sep 12, 2019 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Ally, Anthem, Caterpillar, CVS, Deere, Oracle, PayPal, Rite Aid, Square, Uber, UnitedHealth and More

The top analyst upgrades, downgrades and initiations for Thursday included AbbVie, Ally Financial, Anthem, Caterpillar, CVS Health, Deere, Oracle, PayPal,…

Chris Lange | Sep 12, 2019 at 8:35 AM EDT

Short Sellers Can’t Make Up Their Minds on Big Pharma

The August 30 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Sep 4, 2019 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Camping World, Cleveland-Cliffs, Coupa, Dollar General, DuPont, Nike, Roku, StoneCo and More

The top analyst upgrades, downgrades and initiations for Wednesday included AbbVie, Camping World, Cleveland-Cliffs, Coupa Software, Dollar General, DuPont, Nike,…

Chris Lange | Aug 27, 2019 at 8:35 AM EDT

Big Pharma Sees a Rising Tide in Short Interest

The August 15 short interest data have been compared with the previous figures, and short interest in most of these…

Lee Jackson | Aug 26, 2019 at 7:40 AM EDT

5 Incredible Blue Chip Stocks With 6% or Higher Dividends

These five companies all pay at least a 6% dividend and offer a reasonable degree of safety. Even if a…

Jon C. Ogg | Aug 20, 2019 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Beyond Meat, Bio-Rad, Dell, HP, Jumia, Nabriva, PG&E, Salesforce, Sarepta and More

The included AbbVie, Beyond Meat, Bio-Rad Laboratories, Dell Technologies, HP, Jumia Technologies, Nabriva Therapeutics, PG&E, Salesforce.com and Sarepta Therapeutics.

Jon C. Ogg | Aug 12, 2019 at 12:10 PM EDT

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current…

1 … 16 17 18 19 20 … 41

AbbVie : ABBV

All AbbVie Articles

Short Sellers Can’t Make Up Their Minds on Big Pharma

20 Dividend Stocks for All Baby Boomers to Retire On

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Big Pharma Sees Rising Tide in Short Interest

6 Large-Cap and Mega-Cap Stocks Where Analysts See Large Upside Potential

Why Dividend-Paying Large-Cap Pharmaceuticals Could Shine in Q4

Top Analyst Upgrades and Downgrades: AbbVie, Boston Beer, Carvana, HD Supply, Marathon Petroleum, Square, Trade Desk, Whirlpool and More

Short Sellers Grow More Selective in Big Pharma

Top Analyst Upgrades and Downgrades: AbbVie, Ally, Anthem, Caterpillar, CVS, Deere, Oracle, PayPal, Rite Aid, Square, Uber, UnitedHealth and More

Short Sellers Can’t Make Up Their Minds on Big Pharma

Top Analyst Upgrades and Downgrades: AbbVie, Camping World, Cleveland-Cliffs, Coupa, Dollar General, DuPont, Nike, Roku, StoneCo and More

Big Pharma Sees a Rising Tide in Short Interest

5 Incredible Blue Chip Stocks With 6% or Higher Dividends

Top Analyst Upgrades and Downgrades: AbbVie, Beyond Meat, Bio-Rad, Dell, HP, Jumia, Nabriva, PG&E, Salesforce, Sarepta and More

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

56% of Americans Have No Estate Plan. Here’s Why That Number Hasn’t Budged.

268 U.S. Cities Now Have $1 Million Starter Homes as Housing Affordability Worsens. Here’s Why

Apple Just Dropped 6%. Here’s Why Some Investors Are Buying

56% of Americans Have No Estate Plan. Here's Why That Number Hasn't Budged.

Retired Couple With $2.3M Faces $5,600 IRMAA Surprise After Selling Rental Property

56% of Americans Have No Estate Plan. Here’s Why That Number Hasn’t Budged.

268 U.S. Cities Now Have $1 Million Starter Homes as Housing Affordability Worsens. Here’s Why

AbbVie : ABBV

All AbbVie Articles

Short Sellers Can’t Make Up Their Minds on Big Pharma

20 Dividend Stocks for All Baby Boomers to Retire On

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Big Pharma Sees Rising Tide in Short Interest

6 Large-Cap and Mega-Cap Stocks Where Analysts See Large Upside Potential

Why Dividend-Paying Large-Cap Pharmaceuticals Could Shine in Q4

Top Analyst Upgrades and Downgrades: AbbVie, Boston Beer, Carvana, HD Supply, Marathon Petroleum, Square, Trade Desk, Whirlpool and More

Short Sellers Grow More Selective in Big Pharma

Top Analyst Upgrades and Downgrades: AbbVie, Ally, Anthem, Caterpillar, CVS, Deere, Oracle, PayPal, Rite Aid, Square, Uber, UnitedHealth and More

Short Sellers Can’t Make Up Their Minds on Big Pharma

Top Analyst Upgrades and Downgrades: AbbVie, Camping World, Cleveland-Cliffs, Coupa, Dollar General, DuPont, Nike, Roku, StoneCo and More

Big Pharma Sees a Rising Tide in Short Interest

5 Incredible Blue Chip Stocks With 6% or Higher Dividends

Top Analyst Upgrades and Downgrades: AbbVie, Beyond Meat, Bio-Rad, Dell, HP, Jumia, Nabriva, PG&E, Salesforce, Sarepta and More

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

56% of Americans Have No Estate Plan. Here’s Why That Number Hasn’t Budged.

268 U.S. Cities Now Have $1 Million Starter Homes as Housing Affordability Worsens. Here’s Why

Apple Just Dropped 6%. Here’s Why Some Investors Are Buying

Featured Reads

56% of Americans Have No Estate Plan. Here's Why That Number Hasn't Budged.

Retired Couple With $2.3M Faces $5,600 IRMAA Surprise After Selling Rental Property